0001104659-16-128572.txt : 20160621 0001104659-16-128572.hdr.sgml : 20160621 20160621143308 ACCESSION NUMBER: 0001104659-16-128572 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160617 FILED AS OF DATE: 20160621 DATE AS OF CHANGE: 20160621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILCOX HARRY W CENTRAL INDEX KEY: 0001079136 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 161724113 MAIL ADDRESS: STREET 1: ONE KENDALL SQ STREET 2: BLDG 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0306 4 2016-06-17 0 0001492674 T2 Biosystems, Inc. TTOO 0001079136 WILCOX HARRY W 101 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Stock Option (Right to Buy) 8.56 2016-06-17 4 A 0 17647 0 A 2026-06-16 Common Stock 17647 17647 D The stock option vests and becomes exercisable in 12 substantially equal monthly installments commencing June 17, 2016. /s/ Christopher Martin, Attorney-in-fact 2016-06-21